Success Story: From RFE to EB-1A Approval for A Postdoctoral Researcher in Clinical Research under Premium Processing
Client’s Testimonial:
“Thank you so much for the wonderful news!!!! I am so so happy and relieved that the I-140 EB-1A has finally been approved. It has been a long journey, and I sincerely appreciate all the hard work and support from your team throughout this process!!!"
On January 21st, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Fellow in the Field of Clinical Research (Approval Notice).
General Field: Clinical Research
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Taiwan
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: January 21st, 2026
Processing Time: 4 months, 5 days (Premium Processing Requested)
Case Summary:
Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team successfully secured EB-1A approval for an expert in the field of clinical research from Taiwan, whose groundbreaking work in epidemiology, bioinformatics, and data science has been recognized.
The client holds an M.D. and is currently serving as a postdoctoral research fellow at a leading medical institution. The proposed endeavor focuses on advancing clinical research methodologies to address critical national priorities in disease prevention and healthcare equity.
We demonstrated the client's extraordinary qualifications through compelling evidence: 21 peer-reviewed journal articles (6 first-authored), 52 abstracts (27 first-authored), and 1 first-authored preprint published in elite journals. The client's research has been cited 177 times by researchers in at least 16 countries, with at least 7 publications ranking in the top 0.1% to top 10% most cited articles. Additionally, the client has conducted at least 18 peer reviews for prestigious journals.
The petition included 4 independent advisory opinions from international experts who validated the transformative nature of the contributions. One recommender specializing in machine learning applications in biomedical areas noted:
"There is thus no doubt that [Client] shall continue to produce additional valuable research, both driving progress in the field and bringing immense benefits to national and international concerns."
Our team prepared a comprehensive response emphasizing the real-world impact of the research for RFE. With our assistance, the EB-1A petition was approved in over 4 months under premium processing. It has been an honor to support this remarkable researcher. We extend our sincere best wishes for continued success in advancing critical research that transforms lives.

